Navigation Links
NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Date:9/18/2007

Sept. 17, 2007 -- (BRONX, NY) -- Albert Einstein College of Medicine of Yeshiva University has been awarded a grant of more than $9.25 million from the National Institutes of Health to further the medical schools study of centenarians and the biology of aging.

Led by Dr. Nir Barzilai, director of Einsteins Institute for Aging Research, the research will build on the teams previous work to identify genes that appear to contribute to exceptional longevity in humans, and to assess the associations among these genes with the delay or absence of age-related diseases such as heart attack, stroke, and diabetes. To date, Dr. Barzilai and colleagues have identified several biological markers that, they believe, may have contributed to the health and long lives of the centenarians and their familiesnumbering over 400who have participated in Einsteins Longevity Genes Project.

The NIH grant will support a program of integrated projects, which are aimed at illuminating and expanding the current knowledge of the biological mechanisms of healthy aging. Research goals include:

  • identifying additional genes and genetic variations within genes associated with longevity;

  • identifying the ways these genes and their variants interact in humans;

  • identifying the specific mechanisms of these genes and their variants, as well as their roles in the onset or absence of age-related diseases and/or mental and physical preservation;

  • examining whether these longevity genes are likely to affect the incidence of cardiovascular disease and other life-threatening illnesses in the offspring of centenarians; and

  • examining whether these longevity genes affect the incidence of cognitive impairment in relation to the presence of favorable genotypes and their phenotypic expression.

We are very grateful to the NIH for its support, said Dr. Barzilai, who also is the Ingeborg and Ira Leon Rennert Professor of Aging Research at Einstein, as well as professor of medicine and of molecular genetics. We have in place a strong interdisciplinary team of Einstein investigators, including specialists in the fields of gerontology, neurology, genetics, epidemiology, and statistical genetics. These exceptional individuals have collaborated on our previous longevity research and we will continue our work together in this critical next phase, afforded by the NIH grant.

He added, Ultimately, our goal is to learn, on a biomechanical and molecular basis, how to prevent heart disease, strokes, dementia, and other ailments associated with aging. We anticipate that these insights could lead to new modes of prevention against and treatment strategies for these diseases. As such, we believe that our research will have a profound impact on both the length and quality of life for all of us.


'/>"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: